Moshe Levi

Moshe Levi

Auto-generated profile, based on publicly available information

Moshe Levi

Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colorado

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2011 in Circulation
Verified
Journal Article
Closed access
MMMichael Miller
Michael Miller
NSNeil J. Stone
Neil J. Stone
CBChristie Ballantyne
Christie Ballantyne
VBVera Bittner
Vera Bittner
MCMichael H. Criqui
Michael H. Criqui
SPSubramanian Pennathur
Subramanian Pennathur

1 March 2001 in Biophysical Journal
Verified
Journal Article
Closed access
CDC. Dietrich
C. Dietrich
LBLuis A. Bagatolli
Luis A. Bagatolli
ZVZ.N. Volovyk
Z.N. Volovyk
NTN.L. Thompson
N.L. Thompson
MLM. Levi
M. Levi
EGE. Gratton
E. Gratton

3 March 1998 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MSMichio Shimabukuro
Michio Shimabukuro
YZYan-Ting Zhou
Yan-Ting Zhou
MLMoshe Levi
Moshe Levi
RURoger H. Unger
Roger H. Unger
Like obese humans, Zucker diabetic fatty (ZDF) rats exhibit early β cell compensation for insulin resistance (4-fold β cell hyperplasia) followed by decompensation (>50% loss of β cells). In prediabetic and diabetic ZDF islets, apoptosis measured by DNA laddering is increased 3- and >7-fold, respectively, compared with lean ZDF controls. Ceramide, a fatty acid-containing messenger in cytokine-induced apoptosis, was significantly increased ( P < 0.01) in prediabetic and diabetic islets. Free fatty acids (FFAs) in plasma are high (>1 mM) in prediabetic and diabetic ZDF rats; therefore, we cultured prediabetic islets in 1 mM FFA. DNA laddering rose to 19.6% vs. 4.6% in lean control islets, preceded by an 82% increase in ceramide. C 2 -Ceramide without FFA induced DNA laddering, but fumonisin B 1 , a ceramide synthetase inhibitor, completely blocked FFA-induced DNA laddering in cultured ZDF islets. [ 3 H]Palmitate incorporation in [ 3 H]ceramide in ZDF islets was twice that of controls, but [ 3 H]palmitate oxidation was 77% less. Triacsin C, an inhibitor of fatty acyl-CoA synthetase, and troglitazone, an enhancer of FFA oxidation in ZDF islets, both blocked DNA laddering. These agents also reduced inducible nitric oxide (NO) synthase mRNA and NO production, which are involved in FFA-induced apoptosis. In ZDF obesity, β cell apoptosis is induced by increased FFA via de novo ceramide formation and increased NO production.

1 October 1999 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
SHS. Heymans
S. Heymans
ALAernout Luttun
Aernout Luttun
DND. Nuyens
D. Nuyens
GTG. Theilmeier
G. Theilmeier
ECE. Creemers
E. Creemers
PCPeter Carmeliet
Peter Carmeliet

1 March 2014 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
MHMichal Herman-Edelstein
Michal Herman-Edelstein
PSPnina Scherzer
Pnina Scherzer
ATAna Tobar
Ana Tobar
MLMoshe Levi
Moshe Levi
UGUzi Gafter
Uzi Gafter
Animal models link ectopic lipid accumulation to renal dysfunction, but whether this process occurs in the human kidney is uncertain. To this end, we investigated whether altered renal TG and cholesterol metabolism results in lipid accumulation in human diabetic nephropathy (DN). Lipid staining and the expression of lipid metabolism genes were studied in kidney biopsies of patients with diagnosed DN (n = 34), and compared with normal kidneys (n = 12). We observed heavy lipid deposition and increased intracellular lipid droplets. Lipid deposition was associated with dysregulation of lipid metabolism genes. Fatty acid β-oxidation pathways including PPAR-α, carnitine palmitoyltransferase 1, acyl-CoA oxidase, and L-FABP were downregulated. Downregulation of renal lipoprotein lipase, which hydrolyzes circulating TGs, was associated with increased expression of angiopoietin-like protein 4. Cholesterol uptake receptor expression, including LDL receptors, oxidized LDL receptors, and acetylated LDL receptors, was significantly increased, while there was downregulation of genes effecting cholesterol efflux, including ABCA1, ABCG1, and apoE. There was a highly significant correlation between glomerular filtration rate, inflammation, and lipid metabolism genes, supporting a possible role of abnormal lipid metabolism in the pathogenesis of DN. These data suggest that renal lipid metabolism may serve as a target for specific therapies aimed at slowing the progression of glomerulosclerosis.

1 September 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TJTao Jiang
Tao Jiang
ZWZhuowei Wang
Zhuowei Wang
GPGregory Proctor
Gregory Proctor
SMShevie Moskowitz
Shevie Moskowitz
SLScott E. Liebman
Scott E. Liebman
MLMoshe Levi
Moshe Levi
Obesity and metabolic syndrome are associated with glomerulosclerosis and proteinuria, but the mechanisms are not known. The purpose of this study was to determine if there is altered renal lipid metabolism and increased expression of sterol regulatory element-binding proteins (SREBPs) in a model of diet-induced obesity. C57BL/6J mice that were fed a high fat, 60 kcal % saturated (lard) fat diet (HFD) developed obesity, hyperglycemia, and hyperinsulinemia compared with those that were fed a low fat, 10 kcal % fat diet (LFD). In contrast, A/J mice were resistant when fed the same diet. C57BL/6J mice with HFD exhibited significantly higher levels of renal SREBP-1 and SREBP-2 expression than those mice with LFD, whereas in A/J mice there were no changes with the same treatment. The increases in SREBP-1 and SREBP-2 expression in C57BL/6J mice resulted in renal accumulation of triglyceride and cholesterol. There were also significant increases in the renal expression of plasminogen activator inhibitor-1 (PAI-1), vascular endothelial growth factor (VEGF), type IV collagen, and fibronectin, resulting in glomerulosclerosis and proteinuria. To determine a role for SREBPs per se in modulating renal lipid metabolism and glomerulosclerosis we performed studies in SREBP-1c–/– mice. In contrast to control mice, in the SREBP-1c–/– mice with HFD the accumulation of triglyceride was prevented, as well as the increases in PAI-1, VEGF, type IV collagen, and fibronectin expression. Our results therefore suggest that diet-induced obesity causes increased renal lipid accumulation and glomerulosclerosis in C57BL/6J mice via an SREBP-1c-dependent pathway.